Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases.

Journal: Radiation oncology (London, England)
Published Date: May 28, 2016

Abstract

BACKGROUND: We retrospectively evaluated the efficacy and toxicity of gross tumor volume (GTV) mean-dose-optimized and real-time motion-compensated robotic stereotactic body radiation therapy (SBRT) in the treatment of liver metastases.

Authors

  • Nicolaus Andratschke
    Department of Radiation Oncology, University Medicine Rostock, Rostock, Germany. nicolaus.andratschke@usz.ch.
  • Alan Parys
    Department of Radiation Oncology, University Medicine Rostock, Rostock, Germany.
  • Susanne Stadtfeld
    Department of Radiation Oncology, University Hospital Frankfurt, Frankfurt, Germany.
  • Stefan Wurster
    Department of Radiation Oncology, University Medicine Greifswald, Greifswald, Germany.
  • Stefan Huttenlocher
    Saphir Radiosurgery Center, Frankfurt, Güstrow, Germany.
  • Detlef Imhoff
    Department of Radiation Oncology, University Hospital Frankfurt, Frankfurt, Germany.
  • Müjdat Yildirim
    Department of Radiation Oncology, University Hospital Frankfurt, Frankfurt, Germany.
  • Dirk Rades
    Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Lübeck, Germany.
  • Claus Michael Rödel
    Department of Radiation Oncology, University Hospital Frankfurt, Frankfurt, Germany.
  • Jürgen Dunst
    Universitätsklinikum Schleswig-Holstein, Klinik für Strahlentherapie, Kiel, Germany; University Clinic Copenhagen, Department of Radiation Oncology, Copenhagen, Denmark.
  • Guido Hildebrandt
    Universitätsklinikum Rostock, Klinik für Strahlentherapie, Rostock, Germany.
  • Oliver Blanck

Keywords

External Resources

Popular Topics
Recent Journals